Information Provided By: 
Fly News Breaks for March 5, 2020
MDRX
Mar 5, 2020 | 07:00 EDT
SunTrust analyst Sandy Draper lowered the firm's price target on Allscripts to $9 from $11 and keeps a Hold rating on the shares after its Q4 earnings miss and below-consensus guidance for FY20. The analyst notes that the new year will likely be as uneven as FY19, with bookings and revenue not likely to grow given the tough comps and attrition, while the company will look to optimize its operations with further cuts and possibly some asset sales.
News For MDRX From the Last 2 Days
There are no results for your query MDRX
